Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

BACKGROUND: Among breast cancers, the triple-negative breast cancer (TNBC) subtype has the worst prognosis with no approved targeted therapies and only standard chemotherapy as the backbone of systemic therapy. Unique metabolic changes in cancer progression provide innovative therapeutic opportuniti...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Metab
Main Authors: Lanning, Nathan J., Castle, Joshua P., Singh, Simar J., Leon, Andre N., Tovar, Elizabeth A., Sanghera, Amandeep, MacKeigan, Jeffrey P., Filipp, Fabian V., Graveel, Carrie R.
Format: Artigo
Language:Inglês
Published: BioMed Central 2017
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568171/
https://ncbi.nlm.nih.gov/pubmed/28852500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0168-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items